Back
Corvus Pharmaceuticals Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
56
CRVS
Corvus Pharmaceuticals
Last Price:
8.18
Seasonality Move:
-6.15%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bearish and CRVS is experiencing slight buying pressure.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.86 | Sell |
| 20-day SMA: | 8.61 | Sell |
| 50-day SMA: | 6.77 | Buy |
| 200-day SMA: | 3.41 | Buy |
| 8-day EMA: | 8.71 | Sell |
| 20-day EMA: | 8.37 | Sell |
| 50-day EMA: | 7.03 | Buy |
| 200-day EMA: | 4.18 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 51.74 | Buy |
| Chaikin Money Flow: | 289590 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.39 - 9.15) | Sell |
| Bollinger Bands (100): | (2.53 - 7.19) | Buy |
Corvus Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 8.19 while CRVS 8-day simple moving average is 8.86, which is a Sell signal.
- The stock price of CRVS is 8.19 while Corvus Pharmaceuticals 20-day SMA is 8.61, which makes it a Sell.
- Corvus Pharmaceuticals 50-day simple moving average is 6.77 while CRVS share price is 8.19, making it a Buy technically.
- CRVS stock price is 8.19 and Corvus Pharmaceuticals 200-day simple moving average is 3.41, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a Buy
The current Corvus Pharmaceuticals [CRVS] share price is $8.19. The Score for CRVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
512.3M
Price in USD:
8.19
Share Volume:
2.35M
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.30
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?
The Corvus Pharmaceuticals stock price is 8.19 USD today. -
Will CRVS stock go up or go down?
Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Corvus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is not overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 8.19 while CRVS 8-day exponential moving average is 8.71, which is a Sell signal.
- The stock price of CRVS is 8.19 while Corvus Pharmaceuticals 20-day EMA is 8.37, which makes it a Sell.
- Corvus Pharmaceuticals 50-day exponential moving average is 7.03 while CRVS share price is 8.19, making it a Buy technically.
- CRVS stock price is 8.19 and Corvus Pharmaceuticals 200-day simple moving average is 4.18, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.42 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
- CRVS Moving Average Covergence Divergence (MACD) indicator is 0.59, suggesting Corvus Pharmaceuticals is a Buy
- Corvus Pharmaceuticals Relative Strength Index (RSI) is 51.74, which suggest Corvus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Corvus Pharmaceuticals is (7.39 - 9.15), which suggest Corvus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Corvus Pharmaceuticals is (2.53 - 7.19), which suggest Corvus Pharmaceuticals is a Buy
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.